Growth Metrics

Anavex Life Sciences (AVXL) Enterprise Value (QoQ) (2011 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Anavex Life Sciences 266.20 Mn 134.45 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 -28.44%
Sep 30, 2025 -1.40%
Jun 30, 2025 12.62%
Mar 31, 2025 4.14%
Dec 31, 2024 8.63%
Sep 30, 2024 4.73%
Jun 30, 2024 0.45%
Mar 31, 2024 3.05%
Dec 31, 2023 4.81%
Sep 30, 2023 2.45%
Jun 30, 2023 -0.88%
Mar 31, 2023 -6.85%
Dec 31, 2022 3.71%
Sep 30, 2022 2.64%
Jun 30, 2022 0.09%
Mar 31, 2022 -1.45%
Dec 31, 2021 0.63%
Sep 30, 2021 3.46%
Jun 30, 2021 -107.70%
Mar 31, 2021 -60.18%
Dec 31, 2020 -61.91%
Sep 30, 2020 -5.90%
Jun 30, 2020 -3.98%
Mar 31, 2020 3.26%
Dec 31, 2019 -23.77%
Sep 30, 2019 -4.33%
Jun 30, 2019 -9.20%
Mar 31, 2019 6.19%
Dec 31, 2018 9.47%
Sep 30, 2018 11.22%
Jun 30, 2018 -0.67%
Mar 31, 2018 8.53%
Dec 31, 2017 -2.22%
Sep 30, 2017 -10.68%
Jun 30, 2017 -6.17%
Mar 31, 2017 -10.35%
Dec 31, 2016 -130.35%
Sep 30, 2016 5.55%
Sep 30, 2015 -92.07%
Jun 30, 2015 -26.16%
Mar 31, 2015 9.60%
Dec 31, 2014 3.87%
Sep 30, 2014 11.22%
Jun 30, 2014 11.03%
Mar 31, 2014 -9,483.91%
Dec 31, 2013 72.20%
Sep 30, 2013 -20,877.14%
Jun 30, 2013 -237.78%
Mar 31, 2013 99.39%
Dec 31, 2012 -602.24%
Sep 30, 2012 37.55%
Jun 30, 2012 89.82%
Mar 31, 2012 -1,867.69%
Dec 31, 2011 93.26%
Sep 30, 2011 88.98%
Jun 30, 2011 -33,480.17%